Location of Repository

Comparing neurocognitive impairment in schizophrenia and bipolar I disorder using the screen-for-cognitive-impairment-in-psychiatry sale

By Juana Gómez Benito, Georgina Guilera Ferré, Oscar Pino López, Rafael Tabarés-Seisdedos and 1971- Anabel Martínez-Arán

Abstract

The purpose of this study was to compare the psychometric properties of the Screen for Cognitive Impairment in Psychiatry (SCIP) when applied to patients diagnosed with schizophrenia (n = 126) or bipolar I disorder (n = 76), and also to compare the cognitive impairment in both samples of patients and a control group (n = 83) using the SCIP and a complete neuropsychological battery. The SCIP is a scale intended to quickly and easily assess cognitive impairment in patients with severe psychiatric disorders. The results showed firstly that, in terms of internal consistency, temporal stability, dimensional structure, and criterion-referenced validity, the SCIP provides reliable and valid scores at an equivalent level in both schizophrenia and bipolar I disorder samples. Secondly, it showed that differential cognitive impairment between the two patient groups occurs only in verbal memory, although the effect size of the difference is small. Finally, compared with the control group, cognitive impairment was present at all levels in both groups of patients using both the SCIP and the neuropsychological battery, which indicates that the SCIP is a good screening tool for cognitive deficits in schizophrenia and bipolar and useful in clinical practice for healthcare professionals

Topics: Trastorn bipolar, Esquizofrènia, Trastorns de la cognició, Manic-depressive illness, Schizophrenia, Cognition disorders
Publisher: Asociación Española de Psicología Conductual (AEPC)
Year: 2014
DOI identifier: 10.1016/S1697-2600(14)70046-8
OAI identifier: oai:diposit.ub.edu:2445/59232
Journal:

Suggested articles

Preview


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.